Reward-aversion circuitry in analgesia and pain: Implications for psychiatric disorders

被引:92
作者
Borsook, David [1 ]
Becerra, Lino
Carlezon, William A., Jr.
Shaw, Marnie
Renshaw, Perry
Elman, Igor
Levine, Jon
机构
[1] McLean Hosp, Brain Imaging Ctr, Dept Psychiat, PAIN Grp, Belmont, MA 02748 USA
[2] Harvard Univ, Sch Med, Belmont, MA 02748 USA
[3] McLean Hosp, Behav Genet Lab, Belmont, MA 02748 USA
[4] McLean Hosp, Behav Psychopharmacol Res Lab, Belmont, MA 02748 USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
关键词
pain; reward; functional imaging; functional illness; depression; anxiety;
D O I
10.1016/j.ejpain.2005.12.005
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Sensory and emotional systems normally interact in a manner that optimizes an organism's ability to survive using conscious and unconscious processing. Pain and analgesia are interpreted by the nervous system as aversive and rewarding processes that trigger specific behavioral responses. Under normal physiological conditions these processes are adaptive. However, under chronic pain conditions, functional alterations of the central nervous system frequently result in maladaptive behaviors. In this review, we examine: (a) the interactions between sensory and emotional systems involved in processing pain and analgesia in the physiological state; (b) the role of reward/aversion circuitry in pain and analgesia; and (c) the role of alterations in reward/aversion circuitry in the development of chronic pain and co-morbid psychiatric disorders. These underlying features have implications for understanding the neurobiology of functional illnesses such as depression and anxiety and for the development and evaluation of novel therapeutic interventions. (C) 2006 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:7 / 20
页数:14
相关论文
共 195 条
[1]   Genetics and epigenetics in major psychiatric disorders - Dilemmas, achievements, applications, and future scope [J].
Abdolmaleky, HM ;
Thiagalingam, S ;
Wilcox, M .
AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (03) :149-160
[2]  
Adler LJ, 1997, ANESTH ANALG, V84, P949
[3]   Noxious heat induces fMRI activation in two anatomically distinct clusters within the nucleus accumbens [J].
Aharon, I ;
Becerraa, L ;
Chabris, CF ;
Borsooka, D .
NEUROSCIENCE LETTERS, 2006, 392 (03) :159-164
[4]   Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons [J].
Akbarian, S ;
Rios, M ;
Liu, RJ ;
Gold, SJ ;
Fong, HF ;
Zeiler, S ;
Coppola, V ;
Tessarollo, L ;
Jones, KR ;
Nestler, EJ ;
Aghajanian, GK ;
Jaenisch, R .
JOURNAL OF NEUROSCIENCE, 2002, 22 (10) :4153-4162
[5]   Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal [J].
Angst, MS ;
Koppert, W ;
Pahl, I ;
Clark, DJ ;
Schmelz, M .
PAIN, 2003, 106 (1-2) :49-57
[6]  
[Anonymous], 2000, NEUROPSYCHOLOGY ANXI
[7]   Chronic pain patients are impaired on an emotional decision-making task [J].
Apkarian, AV ;
Sosa, Y ;
Krauss, BR ;
Thomas, PS ;
Fredrickson, BE ;
Levy, RE ;
Harden, RN ;
Chialvo, DR .
PAIN, 2004, 108 (1-2) :129-136
[8]   Chronic back pain is associated with decreased prefrontal and thalamic gray matter density [J].
Apkarian, AV ;
Sosa, Y ;
Sonty, S ;
Levy, RM ;
Harden, RN ;
Parrish, TB ;
Gitelman, DR .
JOURNAL OF NEUROSCIENCE, 2004, 24 (46) :10410-10415
[9]   Prefrontal cortical hyperactivity in patients with sympathetically mediated chronic pain [J].
Apkarian, AV ;
Thomas, PS ;
Krauss, BR ;
Szeverenyi, NM .
NEUROSCIENCE LETTERS, 2001, 311 (03) :193-197
[10]   A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder [J].
Arnold, LM ;
Lu, YL ;
Crofford, LJ ;
Wohlreich, M ;
Detke, MJ ;
Iyengar, S ;
Goldstein, DJ .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2974-2984